The French clinical stage company focused on cardiac innovation received the funds from a Series C funding round and the EC’s Med4Cure innovation fund.

In connection with Dr. Bhalla’s appointment, Eric Adler , MD, currently Head of Research at Lexeo Therapeutics, will serve as President and Chief Executive Officer of cardiac precision medicines ...

Company's growing data ecosystem supports the development of large data models for its future predictive technologies and Cardiac AI cloud platform Company has analyzed over 360 Billion heartbeats and ...

Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to develop a new platform ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of - and repair ...

Heart disease remains the leading cause of death worldwide, yet progress in understanding and treating cardiac disorders is limited by the shortcomings of existing experimental models. Traditional ...

Mechanical cues are key regulators of cardiac development, yet their role in organoid maturation remains underexplored. In a new study, researchers introduce a magnetic torque stimulation (MTS) system ...

When the workload on the heart increases, the ventricular wall may thicken too, known as cardiac hypertrophy. This is an adaptive response that reduces pressure on the heart and maintains the activity ...

DUBLIN & MUNICH--(BUSINESS WIRE)--OneProjects, developer of four-dimensional (4D) cardiac imaging technology, today announced a total of $17 million in new financing for the company, including an $8 ...